| Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology AB Benson, MI D’Angelica, DE Abbott, DA Anaya, R Anders, C Are, ... Journal of the National Comprehensive Cancer Network 19 (5), 541-565, 2021 | 620 | 2021 |
| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 550* | 2021 |
| Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells LM Postovit, NV Margaryan, EA Seftor, DA Kirschmann, A Lipavsky, ... Proceedings of the National Academy of Sciences 105 (11), 4329-4334, 2008 | 355 | 2008 |
| NCCN guidelines insights: hepatobiliary cancers, version 1.2017 AB Benson, MI D'Angelica, DE Abbott, TA Abrams, SR Alberts, DA Anaya, ... Journal of the National Comprehensive Cancer Network 15 (5), 563-573, 2017 | 336 | 2017 |
| NCCN guidelines insights: Hepatobiliary cancers, version 2.2019: Featured updates to the NCCN guidelines AB Benson, MI D’Angelica, DE Abbott, TA Abrams, SR Alberts, DA Anaya, ... Journal of the National Comprehensive Cancer Network 17 (4), 302-310, 2019 | 262 | 2019 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 261 | 2021 |
| A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy AH Zureikat, LM Postlewait, Y Liu, TW Gillespie, SM Weber, DE Abbott, ... Annals of surgery 264 (4), 640-649, 2016 | 258 | 2016 |
| Risk factors and consequences of anastomotic leak after colectomy: a national analysis EF Midura, D Hanseman, BR Davis, SJ Atkinson, DE Abbott, SA Shah, ... Diseases of the Colon & Rectum 58 (3), 333-338, 2015 | 222 | 2015 |
| Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival CWD Tzeng, HST Cao, JE Lee, PWT Pisters, GR Varadhachary, RA Wolff, ... Journal of Gastrointestinal Surgery 18 (1), 16-25, 2014 | 204 | 2014 |
| Effect of hospital safety-net burden on cost and outcomes after surgery RS Hoehn, K Wima, MA Vestal, DJ Weilage, DJ Hanseman, DE Abbott, ... JAMA surgery 151 (2), 120-128, 2016 | 174 | 2016 |
| Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome DE Abbott, A Brouquet, EA Mittendorf, A Andreou, F Meric-Bernstam, ... Surgery 151 (5), 710-716, 2012 | 146 | 2012 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 143 | 2020 |
| Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine/nab-paclitaxel chemotherapy in resected pancreatic cancer FI Macedo, E Ryon, SK Maithel, RM Lee, DA Kooby, RC Fields, ... Annals of surgery 270 (3), 400-413, 2019 | 136 | 2019 |
| Long-term outcomes after total pancreatectomy and islet cell autotransplantation: is it a durable operation? GC Wilson, JM Sutton, DE Abbott, MT Smith, AM Lowy, JB Matthews, ... Annals of surgery 260 (4), 659-667, 2014 | 132 | 2014 |
| Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer RP Merkow, DJ Bentrem, MF Mulcahy, JW Chung, DE Abbott, TE Kmiecik, ... Annals of surgery 258 (6), 847-853, 2013 | 117 | 2013 |
| The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms Annals of surgical oncology 27 (6), 1753-1760, 2020 | 116* | 2020 |
| Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migration LM Postovit, DE Abbott, SL Payne, WW Wheaton, NV Margaryan, ... Journal of cellular biochemistry 103 (5), 1369-1378, 2008 | 115 | 2008 |
| Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients DA Kooby, NL Lad, MH Squires III, SK Maithel, JM Sarmiento, CA Staley, ... Annals of surgery 260 (3), 494-503, 2014 | 113 | 2014 |
| EphA2 as a promoter of melanoma tumorigenicity NV Margaryan, L Strizzi, DE Abbott, EA Seftor, MS Rao, MJ Hendrix, ... Cancer biology & therapy 8 (3), 279-288, 2009 | 104 | 2009 |
| Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner CM Bailey, DE Abbott, NV Margaryan, Z Khalkhali-Ellis, MJC Hendrix Molecular and cellular biology 28 (7), 2235-2243, 2008 | 104 | 2008 |
